Langsteger W - Search Results

1

Molecular imaging of bone metastases using tumor-targeted tracers.

Karamzade-Ziarati N, Manafi-Farid R, Ataeinia B, Langsteger W, Pirich C, Mottaghy FM, Beheshti M. Karamzade-Ziarati N, et al. Among authors: langsteger w. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):136-149. doi: 10.23736/S1824-4785.19.03206-0. Epub 2019 Jul 16. Q J Nucl Med Mol Imaging. 2019. PMID: 31315347 Review.

2

Imaging of bone metastases in prostate cancer: an update.

Langsteger W, Haim S, Knauer M, Waldenberger P, Emmanuel K, Loidl W, Wolf I, Beheshti M. Langsteger W, et al. Q J Nucl Med Mol Imaging. 2012 Oct;56(5):447-58. Q J Nucl Med Mol Imaging. 2012. PMID: 23069924 Review.

3

(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, Strobel K, Celli M, Fanti S, Giammarile F, Krause B, Langsteger W. Beheshti M, et al. Among authors: langsteger w. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1767-1777. doi: 10.1007/s00259-015-3138-y. Epub 2015 Jul 23. Eur J Nucl Med Mol Imaging. 2015. PMID: 26201825

4

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Hammer J, Loidl W, Pirich C, Fogelman I, Langsteger W. Beheshti M, et al. Among authors: langsteger w. Mol Imaging Biol. 2009 Nov-Dec;11(6):446-54. doi: 10.1007/s11307-009-0217-0. Mol Imaging Biol. 2009. PMID: 19326171

5

The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Hammer J, Loidl W, Pirich C, Fogelman I, Langsteger W. Beheshti M, et al. Among authors: langsteger w. Mol Imaging Biol. 2010 Jan-Feb;12(1):98-107. doi: 10.1007/s11307-009-0239-7. Epub 2009 Jul 9. Mol Imaging Biol. 2010. PMID: 19588206

6

Prostate cancer: role of SPECT and PET in imaging bone metastases.

Beheshti M, Langsteger W, Fogelman I. Beheshti M, et al. Among authors: langsteger w. Semin Nucl Med. 2009 Nov;39(6):396-407. doi: 10.1053/j.semnuclmed.2009.05.003. Semin Nucl Med. 2009. PMID: 19801219 Review.

7

Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.

Beheshti M, Rezaee A, Geinitz H, Loidl W, Pirich C, Langsteger W. Beheshti M, et al. Among authors: langsteger w. J Nucl Med. 2016 Oct;57(Suppl 3):55S-60S. doi: 10.2967/jnumed.115.169730. J Nucl Med. 2016. PMID: 27694173 Free article. Review.

8

¹⁸F-NaF-PET/CT and ^99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.

Langsteger W, Rezaee A, Pirich C, Beheshti M. Langsteger W, et al. Semin Nucl Med. 2016 Nov;46(6):491-501. doi: 10.1053/j.semnuclmed.2016.07.003. Epub 2016 Sep 13. Semin Nucl Med. 2016. PMID: 27825429 Review.

9

68Ga-PSMA-HBED Uptake on Cervicothoracic (Stellate) Ganglia, a Common Pitfall on PET/CT.

Beheshti M, Rezaee A, Langsteger W. Beheshti M, et al. Among authors: langsteger w. Clin Nucl Med. 2017 Mar;42(3):195-196. doi: 10.1097/RLU.0000000000001518. Clin Nucl Med. 2017. PMID: 28033219

10

Therapy assessment of bone metastatic disease in the era of ²²³radium.

Etchebehere E, Brito AE, Rezaee A, Langsteger W, Beheshti M. Etchebehere E, et al. Among authors: langsteger w. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):84-96. doi: 10.1007/s00259-017-3734-0. Epub 2017 May 31. Eur J Nucl Med Mol Imaging. 2017. PMID: 28567494 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page